Treatment of severe invasive Streptococcus pyogenes infections has traditionally relied on β-lactam antibiotics with adjunctive clindamycin. Rising rates of lincosamide resistance have prompted use of linezolid as an alternative adjunctive therapy in some settings. The report summarized here describes detection of a mobile genetic element in a clinical S. pyogenes isolate that carries a cfr-like gene previously associated with linezolid and broader PhLOPSA resistance in other species.
The clinical strain, designated GAS-390756, was a pharyngeal isolate recovered from a child diagnosed with pharyngitis in the United States. The abstract reports that this isolate was analyzed by whole-genome sequencing. Additional case details such as patient course, prior antibiotic exposure, and epidemiologic links were not reported in the abstract.
Whole-genome sequence analysis determined that GAS-390756 belonged to emm type 89. Sequence data identified an integrative and conjugative element in the genome that the authors named ICE Spy 390756. The ICE carried multiple resistance-associated cargo genes noted in the abstract.
ICE Spy 390756 was reported to contain at least two resistance-associated genes: erm(B) and a cfr-like gene termed cfr(C). The erm(B) gene encodes a ribosomal methyltransferase widely associated with macrolide and lincosamide resistance. The cfr family of genes in other bacteria confers a methylation-based resistance mechanism that can produce the PhLOPSA phenotype (resistance to phenicols, lincosamides, oxazolidinones including linezolid, pleuromutilins, and streptogramin A).
Phenotypic antimicrobial susceptibility testing of GAS-390756 showed resistance to erythromycin and clindamycin, consistent with expression of erm(B). Despite carrying cfr(C), the isolate remained susceptible to linezolid in testing reported in the abstract. This genotype–phenotype discordance is addressed in the comparative genomic findings described below.
The authors performed comparative analysis of the genomic context surrounding cfr(C). That analysis suggested the promoter sequence upstream of cfr(C) may have been lost during acquisition of the gene by ICE Spy 390756. Loss of a functional promoter could plausibly explain the absence of a cfr(C)-associated resistance phenotype (that is, lack of linezolid resistance) in this isolate. The abstract does not provide detailed sequence coordinates, promoter sequence alignments, expression data, or functional assays to confirm reduced or absent transcription.
Detection of a mobile element in S. pyogenes that harbors a cfr-like gene is noteworthy because cfr genes have been linked to resistance to linezolid and other drug classes in multiple bacterial species. The presence of such a gene on an ICE raises concern about potential horizontal transfer to other streptococcal strains or species where the gene might be functional. However, in this reported isolate cfr(C) did not confer phenotypic linezolid resistance, likely due to the apparent loss of its promoter. The abstract underscores the importance of genomic surveillance to identify mobile resistance determinants before they become phenotypically active or widely disseminated.
The abstract provides a concise summary of genomic and phenotypic findings but omits several experimental and epidemiologic details. The following were not reported in the abstract: whether gene expression assays (for example, RT-PCR) confirmed absent or reduced cfr(C) transcription; whether functional experiments (cloning, complementation, or conjugation assays) tested transferability or the capacity of cfr(C) to confer resistance in a different host; broader surveillance data on the prevalence of ICE Spy 390756 or cfr(C) among S. pyogenes isolates; and detailed clinical information about the patient or treatment outcomes. These gaps limit definitive conclusions about the element’s mobility, potential to activate resistance, and immediate clinical impact.
A pharyngeal emm type 89 S. pyogenes isolate from a child with pharyngitis carried an integrative and conjugative element (ICE Spy 390756) encoding erm(B) and a cfr-like gene (cfr(C)). The isolate was phenotypically resistant to erythromycin and clindamycin but remained susceptible to linezolid. Comparative genomic data in the abstract suggest loss of the cfr(C) promoter may explain the lack of a cfr(C)-mediated resistance phenotype. The finding highlights the need for continued genomic surveillance of mobile resistance elements in S. pyogenes; several experimental and epidemiologic details were not reported in the abstract and would be required to assess transfer risk and functional impact more fully.